Patient Care

Social Interaction May Enhance Patient Survival After Chemotherapy

Social connections among patients during chemotherapy may play a part in survival rates and disease outcomes.


 

Being with other patients during chemotherapy—rather than isolated—may have long-term effects after chemotherapy, according to researchers from the National Human Genome Research Institute and the University of Oxford in the United Kingdom.

“People model behavior based on what’s around them,” said Jeff Lienert, lead author. “For example, you will often eat more when you’re dining with friends, even if you can’t see what they’re eating.” The researchers wanted to find out whether similar social interaction would influence chemotherapy patients.

Related: Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA

The researchers used data on 4,691 cancer patients. As a proxy for social connection, the researchers gathered information on when patients checked in and out of the chemotherapy ward and how long they spent there, in “a small intimate space” where people could interact for a long period.

“Co-presence matters,” the researchers say. They found that when patients were around other patients who died in less than 5 years, they had a 72% chance of dying within 5 years. The best outcome, the researchers said, was when patients interacted with someone who survived for 5 or more years: Their risk of dying within 5 years dropped to 68%. “Being connected to a single survivor is similarly protective,” the researchers concluded, “as being connected to a single nonsurvivor is deleterious to patient survival.”

Because the study focused on “mere co-presence”—that is, just being together—their findings likely underestimate the influence of social forces, the researchers say. However, they note that “just being around others receiving treatment with similar stressors does not seem to impart any health effects”—suggesting that social facilitation and social support are not the underlying influence mechanism.

Related: Advances in Targeted Therapy for Breast Cancer

The study is the first to investigate, on a large scale, how social context in a treatment setting can play a significant role in disease outcomes. The researchers didn’t study why the difference in survival occurred, but they suggest that stress response may play a role. If a patient is unable to “fight or flee,” as in the situation of chemotherapy, Lienert says, the hormones can build. “Positive social support during the exact moments of greatest stress is crucial.”

Sources:

Lienert J, Marcum CS, Finney J, Reed-Tsochas F, Koehly L. Network Sci . 2017:1-20. https://www.cambridge.org/core/journals/network-science/article/social-influence-on-5year-survival-in-a-longitudinal-chemotherapy-ward-copresence-network/4E08D5F5A0D332AA5BB119310833A244. Accessed August 8, 2017.

National Institutes of Health. Social interaction affects cancer patients’ response to treatment. https://www.nih.gov/news-events/news-releases/social-interaction-affects-cancer-patients-response-treatment. Published July 19, 2017. Accessed August 8, 2017.

Recommended Reading

Dependence of Elevated Eosinophil Levels on Geographic Location
Federal Practitioner
Defining Pharmacy Leadership in the VA
Federal Practitioner
SMILE, Your Myopia Has Just Been Treated Faster!
Federal Practitioner
Examining How the Body Responds to Ebola
Federal Practitioner
Unique Military and VA Nurse Collaboration to Teach and Learn
Federal Practitioner
VA and DoE to Use Supercomputing for Transformative Science
Federal Practitioner
June 2017 Digital Edition
Federal Practitioner
Symptoms Mimicking Those of Hypokalemic Periodic Paralysis Induced by Soluble Barium Poisoning
Federal Practitioner
Collaboration of the NIH and PHS Commissioned Corps in the International Ebola Clinical Research Response
Federal Practitioner
The Potential Dangers of Treating Chronic Lyme Disease
Federal Practitioner

Related Articles